Recalls and alerts more than 4 years old are automatically archived. While this information can still be accessed in the database, it has not been altered or updated since it was archived. Web pages that are archived on the Web are not subject to the Government of Canada Web Standards. As per the Communications Policy of the Government of Canada, you can request alternate formats by contacting us.

X-LipiRaze (March 09, 2011)

Starting date:
March 09, 2011
Posting date:
April 04, 2011
Type of communication:
Drug Recall
Subcategory:
Natural health products
Hazard classification:
Type III
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-2011A72

Reason

Quantity of the medicinal ingredient Garcinia Cambogia per dosage unit in the product is not in compliance with the declared amount per dosage unit for this ingredient in the product licence application 162354.

Depth of distribution

Retailers

Affected products

X-LipiRaze

DIN, NPN, DIN-HIM

EN 162354

Dosage form

Capsule

Strength

  • Green tea extract (Camellia sinensis) 250mg
  • Gambooge (Garcinia cambogia) 110mg
  • Cissus (Cissus quadrangularis) 5mg
  • Burdock (Arctium lappa) 50mg
  • Juniper (Juniperus communis) 50mg
  • Dandelion (Taraxacum officinalis) 10mg
  • Garlic (Allium sativum) 85mg
  • Policosanol (Saccharum officinarum) 1.7mg
  • Cafféine 20mg
  • L-Lysine (L-Lysine hydrochloride) 31.25mg
  • Chromium (Chromium polynicotinate) 0.04mg
  • Magnesium (magnesium oxide) 8.29mg
  • Vitamin B12 (Cyanocobalamin) 0.025mg
  • Niacin (Nicotinic acid) 5mg

Lot or serial number

9H2401, 0H1802

Companies

Recalling Firm
Vitaminol Inc
5900 Henri Bourassa Blvd. West,
Saint-Laurent Quebec
Canada H4R 1V9
Marketing Authorization Holder
Not Applicable